NEW YORK, Aug. 28 (GenomeWeb News) - Transgenomic said today that it has signed securities purchase deals worth a total of $4.5 million with a number of select investors.
The Omaha, Neb.-based company said that the biggest purchasers were two of its largest institutional investors.